Clicky

Depression

Faulty brain circuit helps explain obesity–depression link

Share on PinterestA new study identifies neural links between depression and obesity. Westend61/Getty Images There is a two-way relationship between obesity and mental health conditions, including depression and anxiety. A study in mice suggests that eating a high fat diet may disrupt a newly discovered neural circuit in the brain that governs both mood and […]

Faulty brain circuit helps explain obesity–depression link Read More »

Crisis response teams seeing rise in calls stemming from depression

Separate Rochester and Monroe County crisis response teams are seeing a city-driven rise in calls — mainly to assist people who are suicidal or experiencing chronic mental illness. The county’s Forensic Intervention Team has seen its call volume double from last year, averaging more than nine responses daily — triple that of 2019. While Rochester’s Person In

Crisis response teams seeing rise in calls stemming from depression Read More »

Novel Neural Circuit Targets Link Between Obesity and Depression

Research has found that obesity and mental disorders such as depression and anxiety seem to often go hand in hand. Researchers at Baylor College of Medicine and collaborating institutions are providing new insights into this association by identifying and characterizing a novel neural circuit that mediates the reciprocal control of feeding and psychological states

Novel Neural Circuit Targets Link Between Obesity and Depression Read More »

Exposure To Harmful Chemicals In Plastics May Increase Risk Of Postpartum Depression, Study Finds

Exposure to harmful chemicals in plastic may contribute to postpartum depression. getty In a small study of pregnant women, researchers found that exposure to endocrine-disrupting chemicals commonly found in plastics and products like lipstick, perfumes and lotions – also known as bisphenols (BPA) and phthalates – could contribute to postpartum depression. The study, published in

Exposure To Harmful Chemicals In Plastics May Increase Risk Of Postpartum Depression, Study Finds Read More »

Relmada Therapeutics Announces Initiation of Second Pivotal Phase 3 Study of REL-1017 as Adjunctive Treatment for Patients with Major Depressive Disorder

NEW YORK, April 1, 2021 /PRNewswire/ — Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today announced the initiation of the second of the two sister pivotal Phase 3 clinical trials (RELIANCE I and RELIANCE II) for the Company’s lead product candidate, REL-1017, as an adjunctive

Relmada Therapeutics Announces Initiation of Second Pivotal Phase 3 Study of REL-1017 as Adjunctive Treatment for Patients with Major Depressive Disorder Read More »

Decreases In Exercise Closely Linked With Higher Rates Of Depression During COVID-19

Decreases In Exercise Closely Linked With Higher Rates Of Depression During COVID-19 | OPEN MINDS Decreases in exercise are closely linked with higher rates of depression during coronavirus disease 2019 (COVID-19). From March to July 2020, the average steps of study participants declined from 10,000 to 4,600 steps per

Decreases In Exercise Closely Linked With Higher Rates Of Depression During COVID-19 Read More »

Non-drug interventions effective at easing depression in dementia: study – Clinical Daily News

Non-drug interventions are more effective than drug treatment for reducing symptoms of depression in people with dementia. That’s according to geriatrician-researchers in Canada, who analyzed studies involving more than 25,000 people with depressive symptoms, but no diagnosis of major depressive disorder. Ten interventions were linked to an equal or greater reduction of symptoms than usual

Non-drug interventions effective at easing depression in dementia: study – Clinical Daily News Read More »

Major Depressive Disorder Pipeline Insight Report 2021: Comprehensive Insights About 200+ Companies and 200+ Pipeline Drugs – ResearchAndMarkets.com | Business

DUBLIN–(BUSINESS WIRE)–Mar 31, 2021– The “Major Depressive Disorder – Pipeline Insight, 2021” drug pipelines has been added to ResearchAndMarkets.com‘s offering. This “Major Depressive Disorder – Pipeline Insight, 2021,” report provides comprehensive insights about 200+ companies and 200+ pipeline drugs in Major Depressive Disorder pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical

Major Depressive Disorder Pipeline Insight Report 2021: Comprehensive Insights About 200+ Companies and 200+ Pipeline Drugs – ResearchAndMarkets.com | Business Read More »